These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22234868)

  • 1. TGFβ-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy.
    Bos JM; Subramaniam M; Hawse JR; Christiaans I; Rajamannan NM; Maleszewski JJ; Edwards WD; Wilde AA; Spelsberg TC; Ackerman MJ
    J Cell Biochem; 2012 Jun; 113(6):1896-903. PubMed ID: 22234868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis.
    Hu ZC; Shi F; Liu P; Zhang J; Guo D; Cao XL; Chen CF; Qu SQ; Zhu JY; Tang B
    J Invest Dermatol; 2017 May; 137(5):1051-1059. PubMed ID: 28108300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: Discovery and characterization of a novel signaling pathway.
    Rajamannan NM; Subramaniam M; Abraham TP; Vasile VC; Ackerman MJ; Monroe DG; Chew TL; Spelsberg TC
    J Cell Biochem; 2007 Feb; 100(2):315-25. PubMed ID: 16888812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of transforming growth factor beta (TGFbeta)/Smad transcriptional responses through targeted degradation of TGFbeta-inducible early gene-1 by human seven in absentia homologue.
    Johnsen SA; Subramaniam M; Monroe DG; Janknecht R; Spelsberg TC
    J Biol Chem; 2002 Aug; 277(34):30754-9. PubMed ID: 12072443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.
    Kim J; Shin S; Subramaniam M; Bruinsma E; Kim TD; Hawse JR; Spelsberg TC; Janknecht R
    Biochem Biophys Res Commun; 2010 Oct; 401(3):412-6. PubMed ID: 20863814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The zinc finger transcription factor transforming growth factor beta-inducible early gene-1 confers myeloid-specific activation of the leukocyte integrin CD11d promoter.
    Noti JD; Johnson AK; Dillon JD
    J Biol Chem; 2004 Jun; 279(26):26948-58. PubMed ID: 15087465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts.
    Hawse JR; Cicek M; Grygo SB; Bruinsma ES; Rajamannan NM; van Wijnen AJ; Lian JB; Stein GS; Oursler MJ; Subramaniam M; Spelsberg TC
    PLoS One; 2011 Apr; 6(4):e19429. PubMed ID: 21559363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.
    Bos JM; Poley RN; Ny M; Tester DJ; Xu X; Vatta M; Towbin JA; Gersh BJ; Ommen SR; Ackerman MJ
    Mol Genet Metab; 2006 May; 88(1):78-85. PubMed ID: 16352453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TIEG1 in biological processes and disease states.
    Subramaniam M; Hawse JR; Johnsen SA; Spelsberg TC
    J Cell Biochem; 2007 Oct; 102(3):539-48. PubMed ID: 17729309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort.
    Chen H; Li X; Liu X; Wang J; Zhang Z; Wu J; Huang M; Guo Y; Li F; Wang X; Fu L
    Orphanet J Rare Dis; 2019 Feb; 14(1):29. PubMed ID: 30732632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.
    Landstrom AP; Parvatiyar MS; Pinto JR; Marquardt ML; Bos JM; Tester DJ; Ommen SR; Potter JD; Ackerman MJ
    J Mol Cell Cardiol; 2008 Aug; 45(2):281-8. PubMed ID: 18572189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.
    Arbustini E; Fasani R; Morbini P; Diegoli M; Grasso M; Dal Bello B; Marangoni E; Banfi P; Banchieri N; Bellini O; Comi G; Narula J; Campana C; Gavazzi A; Danesino C; Viganò M
    Heart; 1998 Dec; 80(6):548-58. PubMed ID: 10065021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells.
    Jiang L; Lai YK; Zhang JF; Chan CY; Lu G; Lin MC; He ML; Li JC; Kung HF
    World J Gastroenterol; 2012 May; 18(17):2035-42. PubMed ID: 22563190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFbeta/BMP-6 and TIEG1 in chemotherapy escape.
    Døsen-Dahl G; Munthe E; Nygren MK; Stubberud H; Hystad ME; Rian E
    Int J Cancer; 2008 Dec; 123(12):2759-66. PubMed ID: 18798273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
    Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
    Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human papillomavirus-16 (HPV-16) oncoprotein E7 conjugates with and mediates the role of the transforming growth factor-beta inducible early gene 1 (TIEG1) in apoptosis.
    Chang HS; Lin CH; Yang CH; Liang YJ; Yu WC
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1831-9. PubMed ID: 20691807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis.
    Woo A; Rakowski H; Liew JC; Zhao MS; Liew CC; Parker TG; Zeller M; Wigle ED; Sole MJ
    Heart; 2003 Oct; 89(10):1179-85. PubMed ID: 12975413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway.
    Jin W; Chen BB; Li JY; Zhu H; Huang M; Gu SM; Wang QQ; Chen JY; Yu S; Wu J; Shao ZM
    Mol Cell Biol; 2012 Jan; 32(1):50-63. PubMed ID: 22025675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling.
    Schramm C; Fine DM; Edwards MA; Reeb AN; Krenz M
    Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H231-43. PubMed ID: 22058153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.